Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis

Abstract Background For gastric cancer patients, peritoneal metastasis poses a life-threatening risk due to the high incidence of treatment failure and disease recurrence. Conducting additional research aimed at identifying more efficacious strategies is imperative for enhancing treatment outcomes....

Full description

Saved in:
Bibliographic Details
Main Authors: Yuxi Ma, Yuting Li, Zhenyu Lin, Jing Wang, Jianli Hu, Hongli Liu, Yali Yang, Junli Liu, Tao Zhang
Format: Article
Language:English
Published: BMC 2025-06-01
Series:BMC Cancer
Subjects:
Gastric cancer
Peritoneal metastasis
Chemotherapy
Sintilimab
Bevacizumab
Online Access:https://doi.org/10.1186/s12885-025-14206-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items